ACB - Aurora Cannabis Inc
IEX Last Trade
6.08
0.070 1.151%
Share volume: 660,440
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$6.01
0.07
1.17%
Fundamental analysis
20%
Profitability
0%
Dept financing
12%
Liquidity
75%
Performance
29%
Performance
5 Days
-6.61%
1 Month
3.58%
3 Months
-1.14%
6 Months
88.24%
1 Year
30.89%
2 Year
-60.00%
Key data
Stock price
$6.08
DAY RANGE
N/A - N/A
52 WEEK RANGE
$2.84 - $11.50
52 WEEK CHANGE
$0.29
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Michael Singer
Region: US
Website: https://www.auroramj.com/
Employees: 687
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.auroramj.com/
Employees: 687
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
aurora is a canadian company and licensed producer of artisanal medical marijuana pursuant to the marihuana for medical purposes regulations. we ensure the highest quality, reliability, and safety of our products through advanced cultivation techniques carried out in our 55,200 square foot expandable state-of-the-art production facility in alberta, canada. aurora’s wholly-owned subsidiary, australis capital inc., seeks to be an active participant in the u.s. cannabis market.
Recent news